Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05154929 · ClinicalTrials.gov registry record · NA

Improving Blood Pressure Control Through the myBPmyLife mHealth Application

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
608
Enrollment target

NCT05154929 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 608 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05154929, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
608 participants
Enrollment target

Study Summary

This study is enrolling eligible participants that have high blood pressure. Reducing dietary salt intake and engaging in regular physical activity is known to decrease blood pressure in people with hypertension. This trial will determine whether a smartwatch and a mobile health application, which together deliver notifications, can increase activity levels and reduce salt intake for people with high blood pressure. All study activities will be completed online or via a mobile medical application. Participants will not have any face-to-face visits with the study team.

Interventions

  • OTHER Control Group
  • BEHAVIORAL Dietary and physical activity JITAI delivered through the myBPmyLife app

Trial Details

FieldValue
Enrollment Target 608 participants
Start Date 2021-12-21
Est. Completion 2024-01-27
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT05154929

The ClinicalTrials.gov registry entry for NCT05154929 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 608 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control Group is the first listed.

NCT05154929 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05154929 about?

NCT05154929 is a clinical study titled "Improving Blood Pressure Control Through the myBPmyLife mHealth Application". This study is enrolling eligible participants that have high blood pressure. Reducing dietary salt intake and engaging in regular physical activity is known to decrease blood pressure in people with hypertension. This trial will determine whether a smartwatch and a mobile health application, which t...

What is the current status of trial NCT05154929?

This trial is currently completed. It is a NA study. The enrollment target is 608 participants. The study started on 2021-12-21. Estimated completion is 2024-01-27.

What interventions are being tested in trial NCT05154929?

The interventions under investigation include: Control Group (OTHER), Dietary and physical activity JITAI delivered through the myBPmyLife app (BEHAVIORAL).

Who is sponsoring clinical trial NCT05154929?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.